These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 19138715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):541-5. PubMed ID: 20184936
    [Abstract] [Full Text] [Related]

  • 4. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D, Barak Y, Mirecky I, Mazeh D.
    Int J Geriatr Psychiatry; 2008 Apr 16; 23(4):393-400. PubMed ID: 17879256
    [Abstract] [Full Text] [Related]

  • 5. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM, Lyons D, Shin IS, Yoon JS.
    Hum Psychopharmacol; 2003 Apr 16; 18(3):215-20. PubMed ID: 12672174
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML, Saina M, Trevisiol M, Cristante T, Aguglia E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):205-9. PubMed ID: 17020789
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
    Kawanabe T, Yoritaka A, Shimura H, Oizumi H, Tanaka S, Hattori N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):284-7. PubMed ID: 19948198
    [Abstract] [Full Text] [Related]

  • 8. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K, Tomita N, Uematsu D, Okahara K, Shimada H, Ikeda M, Matsui T, Kozaki K, Fujii M, Ogawa T, Umegaki H, Urakami K, Nomura H, Kobayashi N, Nakanishi A, Washimi Y, Yonezawa H, Takahashi S, Kubota M, Wakutani Y, Ito D, Sasaki T, Matsubara E, Une K, Ishiki A, Yahagi Y, Shoji M, Sato H, Terayama Y, Kuzuya M, Araki N, Kodama M, Yamaguchi T, Arai H.
    Geriatr Gerontol Int; 2017 Feb 17; 17(2):211-218. PubMed ID: 26711658
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.
    Int J Geriatr Psychiatry; 2007 May 17; 22(5):475-84. PubMed ID: 17471598
    [Abstract] [Full Text] [Related]

  • 10. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
    Shinno H, Inami Y, Inagaki T, Nakamura Y, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):881-5. PubMed ID: 18243460
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with behavioral and psychological symptoms of dementia: an open-label study.
    Sumiyoshi H, Mantani A, Nishiyama S, Fujiwaki S, Ohta S, Masuda Y, Tomita Y, Tarumoto N, Yamawaki S.
    Am J Geriatr Psychiatry; 2013 Nov 01; 21(11):1082-5. PubMed ID: 23567442
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Category verbal fluency predicted changes in behavioral and psychological symptoms of dementia in patients with Alzheimer's disease.
    Tsai CF, Wang SJ, Zheng L, Fuh JL.
    Psychiatry Clin Neurosci; 2010 Aug 01; 64(4):408-14. PubMed ID: 20573053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
    Hamuro A, Saito S.
    Psychogeriatrics; 2010 Dec 01; 10(4):198-200. PubMed ID: 21159055
    [Abstract] [Full Text] [Related]

  • 17. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Greenspan A.
    Int J Geriatr Psychiatry; 2005 Dec 01; 20(12):1153-7. PubMed ID: 16315159
    [Abstract] [Full Text] [Related]

  • 18. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V, Haglund A, Kowalski J, Langworth S, Winblad B.
    Dement Geriatr Cogn Disord; 2008 Dec 01; 26(5):458-66. PubMed ID: 18984956
    [Abstract] [Full Text] [Related]

  • 19. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.
    Nagata K, Yokoyama E, Yamazaki T, Takano D, Maeda T, Takahashi S, Terayama Y.
    Phytomedicine; 2012 Apr 15; 19(6):524-8. PubMed ID: 22421528
    [Abstract] [Full Text] [Related]

  • 20. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.
    Yener GG, Turkuaz Alzheimer Working (TAC) Group.
    Cogn Behav Neurol; 2009 Dec 15; 22(4):264-9. PubMed ID: 19996880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.